A Clinical Study Trial of Phenlarmide in China

NCT04164121 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Phenlarmide Tablets
DRUG: Placebos

Sponsor

Yiling Pharmaceutical Inc.